Literature DB >> 26079312

PAX8 expression in ovarian surface epithelial cells.

Emily Adler1, Paulette Mhawech-Fauceglia2, Simon A Gayther3, Kate Lawrenson4.   

Abstract

High-grade serous ovarian carcinoma (HGSOC) is usually diagnosed at a late stage and is associated with poor prognosis. Understanding early stage disease biology is essential in developing clinical biomarkers to detect HGSOC earlier. While recent studies indicate that HGSOCs arise from fallopian tube secretory epithelial cells, a considerable body of evidence suggests that HGSOC can also arise from ovarian surface epithelial cells (OSECs). PAX8 is overexpressed in HGSOCs and expressed in fallopian tube secretory epithelial cells, but there are conflicting reports about PAX8 expression in OSECs. The purposes of this study were to comprehensively characterize PAX8 expression in a large series of OSECs and to investigate the role of PAX8 in early HGSOC development. PAX8 protein expression was analyzed in the OSECs of 27 normal ovaries and 7 primary OSEC cultures using immunohistochemistry and immunofluorescent cytochemistry. PAX8 messenger RNA expression was quantified in 66 primary OSEC cultures. Cellular transformation was evaluated in OSECs expressing a PAX8 construct. PAX8 was expressed by 44% to 71% of OSECs. Calretinin and E-cadherin were frequently coexpressed with PAX8. Expression of PAX8 in OSECs decreased cellular migration (P = .028), but had no other effects on cellular transformation. In addition, PAX8 expression was significantly increased (P = .003) in an in vitro stepwise model of neoplastic transformation. In conclusion, PAX8 is frequently expressed by OSECs, and endogenous levels of PAX8 expression are non-transforming. These data indicate that in OSECs, PAX8 expression may represent a normal state and that OSECs may represent an origin of HGSOCs.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CMYC; Fallopian tube epithelial cells; High-grade serous ovarian carcinoma; Inclusion cyst; Ovarian surface epithelium; PAX8

Mesh:

Substances:

Year:  2015        PMID: 26079312      PMCID: PMC4951208          DOI: 10.1016/j.humpath.2015.03.017

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  35 in total

1.  Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

Authors:  David W Kindelberger; Yonghee Lee; Alexander Miron; Michelle S Hirsch; Colleen Feltmate; Fabiola Medeiros; Michael J Callahan; Elizabeth O Garner; Robert W Gordon; Chandler Birch; Ross S Berkowitz; Michael G Muto; Christopher P Crum
Journal:  Am J Surg Pathol       Date:  2007-02       Impact factor: 6.394

2.  Expression of PAX8 in normal and neoplastic tissues: a comprehensive immunohistochemical study.

Authors:  David Tacha; Ding Zhou; Liang Cheng
Journal:  Appl Immunohistochem Mol Morphol       Date:  2011-07

3.  Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis.

Authors:  Melinda S Yates; Larissa A Meyer; Michael T Deavers; Molly S Daniels; Elizabeth R Keeler; Samuel C Mok; David M Gershenson; Karen H Lu
Journal:  Cancer Prev Res (Phila)       Date:  2011-01-28

4.  Endosalpingiosis in laparoscopy.

Authors:  M H Hesseling; R L De Wilde
Journal:  J Am Assoc Gynecol Laparosc       Date:  2000-05

5.  Emerging roles for PAX8 in ovarian cancer and endosalpingeal development.

Authors:  Nathan J Bowen; Sanjay Logani; Erin B Dickerson; Laura B Kapa; Mariam Akhtar; Benedict B Benigno; John F McDonald
Journal:  Gynecol Oncol       Date:  2006-10-24       Impact factor: 5.482

6.  Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer.

Authors:  Hiu Wing Cheung; Glenn S Cowley; Barbara A Weir; Jesse S Boehm; Scott Rusin; Justine A Scott; Alexandra East; Levi D Ali; Patrick H Lizotte; Terence C Wong; Guozhi Jiang; Jessica Hsiao; Craig H Mermel; Gad Getz; Jordi Barretina; Shuba Gopal; Pablo Tamayo; Joshua Gould; Aviad Tsherniak; Nicolas Stransky; Biao Luo; Yin Ren; Ronny Drapkin; Sangeeta N Bhatia; Jill P Mesirov; Levi A Garraway; Matthew Meyerson; Eric S Lander; David E Root; William C Hahn
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-11       Impact factor: 11.205

7.  A novel mutation (Q40P) in PAX8 associated with congenital hypothyroidism and thyroid hypoplasia: evidence for phenotypic variability in mother and child.

Authors:  T Congdon; L Q Nguyen; C R Nogueira; R L Habiby; G Medeiros-Neto; P Kopp
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

8.  c-myc over-expression in human primary ovarian tumours: its relevance to tumour progression.

Authors:  H Tashiro; K Miyazaki; H Okamura; A Iwai; M Fukumoto
Journal:  Int J Cancer       Date:  1992-03-12       Impact factor: 7.396

9.  Genome-wide analysis of Pax8 binding provides new insights into thyroid functions.

Authors:  Sergio Ruiz-Llorente; Enrique Carrillo Santa de Pau; Ana Sastre-Perona; Cristina Montero-Conde; Gonzalo Gómez-López; James A Fagin; Alfonso Valencia; David G Pisano; Pilar Santisteban
Journal:  BMC Genomics       Date:  2012-04-24       Impact factor: 3.969

10.  An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets.

Authors:  Karen I Zeller; Anil G Jegga; Bruce J Aronow; Kathryn A O'Donnell; Chi V Dang
Journal:  Genome Biol       Date:  2003-09-11       Impact factor: 13.583

View more
  15 in total

Review 1.  The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded.

Authors:  Robert J Kurman; Ie-Ming Shih
Journal:  Am J Pathol       Date:  2016-04       Impact factor: 4.307

2.  The conceptual advances of carcinogenic sequence model in high-grade serous ovarian cancer.

Authors:  Hiroshi Kobayashi; Kana Iwai; Emiko Niiro; Sachiko Morioka; Yuki Yamada; Kenji Ogawa; Naoki Kawahara
Journal:  Biomed Rep       Date:  2017-07-27

3.  Cell transcriptomic atlas of the non-human primate Macaca fascicularis.

Authors:  Lei Han; Xiaoyu Wei; Chuanyu Liu; Giacomo Volpe; Zhenkun Zhuang; Xuanxuan Zou; Zhifeng Wang; Taotao Pan; Yue Yuan; Xiao Zhang; Peng Fan; Pengcheng Guo; Yiwei Lai; Ying Lei; Xingyuan Liu; Feng Yu; Shuncheng Shangguan; Guangyao Lai; Qiuting Deng; Ya Liu; Liang Wu; Quan Shi; Hao Yu; Yunting Huang; Mengnan Cheng; Jiangshan Xu; Yang Liu; Mingyue Wang; Chunqing Wang; Yuanhang Zhang; Duo Xie; Yunzhi Yang; Yeya Yu; Huiwen Zheng; Yanrong Wei; Fubaoqian Huang; Junjie Lei; Waidong Huang; Zhiyong Zhu; Haorong Lu; Bo Wang; Xiaofeng Wei; Fengzhen Chen; Tao Yang; Wensi Du; Jing Chen; Shibo Xu; Juan An; Carl Ward; Zongren Wang; Zhong Pei; Chi-Wai Wong; Xiaolei Liu; Huafeng Zhang; Mingyuan Liu; Baoming Qin; Axel Schambach; Joan Isern; Liqiang Feng; Yan Liu; Xiangyu Guo; Zhen Liu; Qiang Sun; Patrick H Maxwell; Nick Barker; Pura Muñoz-Cánoves; Ying Gu; Jan Mulder; Mathias Uhlen; Tao Tan; Shiping Liu; Huanming Yang; Jian Wang; Yong Hou; Xun Xu; Miguel A Esteban; Longqi Liu
Journal:  Nature       Date:  2022-04-13       Impact factor: 49.962

4.  Proliferation of the Fallopian Tube Fimbriae and Cortical Inclusion Cysts: Effects of the Menstrual Cycle and the Levonorgestrel Intrauterine Contraceptive System.

Authors:  Kay J Park; Vance Broach; Dennis S Chi; Irina Linkov; Frank Z Stanczyk; Prusha Patel; Anjali Jotwani; Celeste Leigh Pearce; Malcolm C Pike; Noah D Kauff
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-09-02       Impact factor: 4.090

Review 5.  PAX8 in the Junction between Development and Tumorigenesis.

Authors:  Reli Rachel Kakun; Zohar Melamed; Ruth Perets
Journal:  Int J Mol Sci       Date:  2022-07-03       Impact factor: 6.208

6.  Observations on the origin of ovarian cortical inclusion cysts in women undergoing risk-reducing salpingo-oophorectomy.

Authors:  Kay J Park; Prusha Patel; Irina Linkov; Anjali Jotwani; Noah Kauff; Malcolm C Pike
Journal:  Histopathology       Date:  2018-01-29       Impact factor: 5.087

7.  Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci.

Authors:  Brett M Reid; Jennifer B Permuth; Y Ann Chen; Jamie K Teer; Alvaro N A Monteiro; Zhihua Chen; Jonathan Tyrer; Andrew Berchuck; Georgia Chenevix-Trench; Jennifer A Doherty; Ellen L Goode; Edwin S Iverson; Kate Lawrenson; Celeste L Pearce; Paul D Pharoah; Catherine M Phelan; Susan J Ramus; Mary Anne Rossing; Joellen M Schildkraut; Jin Q Cheng; Simon A Gayther; Thomas A Sellers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-12-29       Impact factor: 4.090

8.  The PAX8 cistrome in epithelial ovarian cancer.

Authors:  Emily K Adler; Rosario I Corona; Janet M Lee; Norma Rodriguez-Malave; Paulette Mhawech-Fauceglia; Heidi Sowter; Dennis J Hazelett; Kate Lawrenson; Simon A Gayther
Journal:  Oncotarget       Date:  2017-11-27

9.  Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci.

Authors:  Siddhartha P Kar; Emily Adler; Jonathan Tyrer; Dennis Hazelett; Hoda Anton-Culver; Elisa V Bandera; Matthias W Beckmann; Andrew Berchuck; Natalia Bogdanova; Louise Brinton; Ralf Butzow; Ian Campbell; Karen Carty; Jenny Chang-Claude; Linda S Cook; Daniel W Cramer; Julie M Cunningham; Agnieszka Dansonka-Mieszkowska; Jennifer Anne Doherty; Thilo Dörk; Matthias Dürst; Diana Eccles; Peter A Fasching; James Flanagan; Aleksandra Gentry-Maharaj; Rosalind Glasspool; Ellen L Goode; Marc T Goodman; Jacek Gronwald; Florian Heitz; Michelle A T Hildebrandt; Estrid Høgdall; Claus K Høgdall; David G Huntsman; Allan Jensen; Beth Y Karlan; Linda E Kelemen; Lambertus A Kiemeney; Susanne K Kjaer; Jolanta Kupryjanczyk; Diether Lambrechts; Douglas A Levine; Qiyuan Li; Jolanta Lissowska; Karen H Lu; Jan Lubiński; Leon F A G Massuger; Valerie McGuire; Iain McNeish; Usha Menon; Francesmary Modugno; Alvaro N Monteiro; Kirsten B Moysich; Roberta B Ness; Heli Nevanlinna; James Paul; Celeste L Pearce; Tanja Pejovic; Jennifer B Permuth; Catherine Phelan; Malcolm C Pike; Elizabeth M Poole; Susan J Ramus; Harvey A Risch; Mary Anne Rossing; Helga B Salvesen; Joellen M Schildkraut; Thomas A Sellers; Mark Sherman; Nadeem Siddiqui; Weiva Sieh; Honglin Song; Melissa Southey; Kathryn L Terry; Shelley S Tworoger; Christine Walsh; Nicolas Wentzensen; Alice S Whittemore; Anna H Wu; Hannah Yang; Wei Zheng; Argyrios Ziogas; Matthew L Freedman; Simon A Gayther; Paul D P Pharoah; Kate Lawrenson
Journal:  Br J Cancer       Date:  2017-01-19       Impact factor: 7.640

10.  Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium.

Authors:  Laura H Rodgers; Eoghainín Ó hAinmhire; Alexandria N Young; Joanna E Burdette
Journal:  Oncotarget       Date:  2016-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.